The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 The global cardiometabolic diseases market is on an upward trajectory, poised to grow from $101.59 billion in 2022 to $106.30 billion in 2023, reflecting a robust compound annual growth rate (CAGR) of 4.64%. By 2027, the market is predicted to reach $123.28 billion, at a CAGR of 3.77%. This growth is driven by a significant factor—rising obesity rates. In this blog, we’ll explore the impact of obesity on cardiometabolic diseases and how the market is evolving to combat this global challenge.

Obesity: A Weighty Matter

• Obesity is a complex condition characterized by excessive body fat accumulation, contributing to health risks.
• It is directly associated with cardiometabolic diseases, including dyslipidemia, type 2 diabetes, hypertension, and sleep disorders.

The Global Obesity Epidemic

• According to the World Health Organization (WHO), over 1 billion people worldwide are affected by obesity. This includes 340 million adolescents, 650 million adults, and 39 million children annually.
• By 2025, WHO predicts that 167 million adults and children will experience health issues due to being overweight or obese.

Major Players in the Cardiometabolic Diseases Market

• Leading companies in the cardiometabolic diseases market include:
  • Pfizer Inc.
  • Johnson & Johnson
  • Hoffmann-La Roche AG
  • Merck & Co Inc.
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Kowa Company Ltd.
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Arrowhead Pharmaceuticals Inc.
  • Cardax Inc.

Innovations Paving the Way

• A noteworthy trend in the cardiometabolic diseases market is the adoption of advanced technologies, helping companies maintain their market positions.

Example: Eko Health’s Sensora Platform

• In February 2023, Eko Health Inc., a US-based creator of digital health technologies for detecting heart and lung diseases, unveiled the Sensora cardiac disease detection platform.
• This platform employs artificial intelligence (AI) to reliably detect structural murmurs, a symptom of valvular heart disease. It also offers care pathway analytics software, providing insights into the patient journey through the healthcare system.
• The Sensora digital stethoscope captures and analyzes electrical impulses and heartbeats, advancing the diagnosis of cardiometabolic diseases.

Segments and Insights

1. By Type:
   • Chronic/Congestive Heart Failure
   • Hypertension
   • Type 2 Diabetes
   • Obesity
2. By Treatment:
   • ACE Inhibitors
   • Diuretics
   • Glucophage
   • Liposuction
   • Other Treatments
3. By Dosage:
   • Tablet
   • Injection
4. By Route of Administration:
   • Oral
   • Intravenous
   • Other Routes of Administration
5. By End-Users:
   • Clinic
   • Hospital
   • Other End-Users

Asia-Pacific: The Rising Star

• In 2022, North America held the title of the largest region in the cardiometabolic diseases market.
• The fastest-growing region in the forecast period is anticipated to be Asia-Pacific, indicating the global demand for advanced cardiometabolic disease management.

View More On The Cardiometabolic Diseases Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report

Request A Sample Of The Global Cardiometabolic Diseases Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=11929&type=smp

The Cardiometabolic Diseases Global Market Report 2023  provides a comprehensive overview on the cardiometabolic diseases market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Point Of Care Diagnostics Global Market Report 2023
Respiratory Monitoring Devices Global Market Report 2023
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model